Level C· Early human research exploring benefitsCohort StudyEurope PMCOpen access

Complement factor H is expressed in adipose tissue in association with insulin resistance

Moreno-Navarrete JM., Martínez-Barricarte R., Catalán V., Sabater M., Gómez-Ambrosi J., Ortega FJ.

Cohort Study with a reported sample of 13 on Type 2 Diabetes, published in Diabetes (2010) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Cohort Study
Journal
Diabetes (2010)
Reported sample size
13
Source database
Europe PMC
PMID
19833879
PMCID
PMC2797922
DOI
10.2337/db09-0700
Citations
102

Abstract (original English)

Objective Activation of the alternative pathway of the complement system, in which factor H (fH; complement fH [CFH]) is a key regulatory component, has been suggested as a link between obesity and metabolic disorders. Our objective was to study the associations between circulating and adipose tissue gene expressions of CFH and complement factor B (fB; CFB) with obesity and insulin resistance. Research design and methods Circulating fH and fB were determined by enzyme-linked immunosorbent assay in 398 subjects. CFH and CFB gene expressions were evaluated in 76 adipose tissue samples, in isolated adipocytes, and in stromovascular cells (SVC) (n = 13). The effects of weight loss and rosiglitazone were investigated in independent cohorts. Results Both circulating fH and fB were associated positively with BMI, waist circumference, triglycerides, and inflammatory parameters and negatively with insulin sensitivity and HDL cholesterol. For the first time, CFH gene expression was detected in human adipose tissue (significantly increased in subcutaneous compared with omental fat). CFH gene expression in omental fat was significantly associated with insulin resistance. In contrast, CFB gene expression was significantly increased in omental fat but also in association with fasting glucose and triglycerides. The SVC fraction was responsible for these differences, although isolated adipocyt

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
OmentumAdipose TissueSkinHumansDiabetes Mellitus, Type 2Insulin ResistanceObesityWeight LossThiazolidinedionesComplement Factor B

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research